Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst

기사 요약

HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.